Literature DB >> 19943124

Adverse stress, hippocampal networks, and Alzheimer's disease.

Sarah M Rothman1, Mark P Mattson.   

Abstract

Recent clinical data have implicated chronic adverse stress as a potential risk factor in the development of Alzheimer's disease (AD) and data also suggest that normal, physiological stress responses may be impaired in AD. It is possible that pathology associated with AD causes aberrant responses to chronic stress, due to potential alterations in the hypothalamic-pituitary-adrenal (HPA) axis. Recent study in rodent models of AD suggests that chronic adverse stress exacerbates the cognitive deficits and hippocampal pathology that are present in the AD brain. This review summarizes recent findings obtained in experimental AD models regarding the influence of chronic adverse stress on the underlying cellular and molecular disease processes including the potential role of glucocorticoids. Emerging findings suggest that both AD and chronic adverse stress affect hippocampal neural networks in a similar fashion. We describe alterations in hippocampal plasticity, which occur in both chronic stress and AD including dendritic remodeling, neurogenesis, and long-term potentiation. Finally, we outline potential roles for oxidative stress and neurotrophic factor signaling as the key determinants of the impact of chronic stress on the plasticity of neural networks and AD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19943124      PMCID: PMC2833224          DOI: 10.1007/s12017-009-8107-9

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  178 in total

Review 1.  Stress and cognition: are corticosteroids good or bad guys?

Authors:  E R de Kloet; M S Oitzl; M Joëls
Journal:  Trends Neurosci       Date:  1999-10       Impact factor: 13.837

2.  A role for adult neurogenesis in spatial long-term memory.

Authors:  J S Snyder; N S Hong; R J McDonald; J M Wojtowicz
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

3.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.

Authors:  Nathan A Johnson; Geon-Ho Jahng; Michael W Weiner; Bruce L Miller; Helena C Chui; William J Jagust; Maria L Gorno-Tempini; Norbert Schuff
Journal:  Radiology       Date:  2005-03       Impact factor: 11.105

Review 4.  Signaling pathways in brain involved in predisposition and pathogenesis of stress-related disease: genetic and kinetic factors affecting the MR/GR balance.

Authors:  E Ronald De Kloet; Roel Derijk
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

Review 5.  Amyloid beta-peptide(1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  Brain Pathol       Date:  2004-10       Impact factor: 6.508

6.  Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

Authors:  Pascale N Lacor; Maria C Buniel; Lei Chang; Sara J Fernandez; Yuesong Gong; Kirsten L Viola; Mary P Lambert; Pauline T Velasco; Eileen H Bigio; Caleb E Finch; Grant A Krafft; William L Klein
Journal:  J Neurosci       Date:  2004-11-10       Impact factor: 6.167

7.  Mitochondrial abnormalities in Alzheimer brain: mechanistic implications.

Authors:  Parvesh Bubber; Vahram Haroutunian; Gene Fisch; John P Blass; Gary E Gibson
Journal:  Ann Neurol       Date:  2005-05       Impact factor: 10.422

8.  Support for a bimodal role for type II adrenal steroid receptors in spatial memory.

Authors:  C D Conrad; S J Lupien; B S McEwen
Journal:  Neurobiol Learn Mem       Date:  1999-07       Impact factor: 2.877

9.  Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission.

Authors:  J P Wisor; D M Edgar; J Yesavage; H S Ryan; C M McCormick; N Lapustea; G M Murphy
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

10.  Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque.

Authors:  J Jacob Kulstad; Pamela J McMillan; James B Leverenz; David G Cook; Pattie S Green; Elaine R Peskind; Charles W Wilkinson; Wesley Farris; Pankaj D Mehta; Suzanne Craft
Journal:  J Neuropathol Exp Neurol       Date:  2005-02       Impact factor: 3.685

View more
  73 in total

1.  Educational attainment and mid-life stress as risk factors for dementia in late life.

Authors:  Lon White
Journal:  Brain       Date:  2010-07-17       Impact factor: 13.501

2.  Alzheimer's disease and epilepsy: insight from animal models.

Authors:  Helen E Scharfman
Journal:  Future Neurol       Date:  2012-03-01

Review 3.  The interesting interplay between interneurons and adult hippocampal neurogenesis.

Authors:  Irene Masiulis; Sanghee Yun; Amelia J Eisch
Journal:  Mol Neurobiol       Date:  2011-09-29       Impact factor: 5.590

Review 4.  Cognitive functioning and late-life depression.

Authors:  Aaron M Koenig; Rishi K Bhalla; Meryl A Butters
Journal:  J Int Neuropsychol Soc       Date:  2014-03-31       Impact factor: 2.892

5.  The involvement of homocysteine in stress-induced Aβ precursor protein misprocessing and related cognitive decline in rats.

Authors:  Fang Xie; Yun Zhao; Jing Ma; Jing-Bo Gong; Shi-Da Wang; Liang Zhang; Xiu-Jie Gao; Ling-Jia Qian
Journal:  Cell Stress Chaperones       Date:  2016-07-19       Impact factor: 3.667

6.  Stress hormone leads to memory deficits and altered tau phosphorylation in a model of Alzheimer's disease.

Authors:  Yash B Joshi; Jin Chu; Domenico Praticò
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

7.  Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model.

Authors:  Cheng Zhang; Ching-Chang Kuo; Setareh H Moghadam; Louise Monte; Kenner C Rice; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Treatment-related alteration of cortisol predicts change in neuropsychological function during acute treatment of late-life anxiety disorder.

Authors:  Eric J Lenze; David Dixon; Rose C Mantella; Peter M Dore; Carmen Andreescu; Charles F Reynolds; John W Newcomer; Meryl A Butters
Journal:  Int J Geriatr Psychiatry       Date:  2011-06-17       Impact factor: 3.485

9.  Chronic stress impairs the aquaporin-4-mediated glymphatic transport through glucocorticoid signaling.

Authors:  Fang Wei; Jian Song; Cui Zhang; Jun Lin; Rong Xue; Li-Dong Shan; Shan Gong; Guo-Xing Zhang; Zheng-Hong Qin; Guang-Yin Xu; Lin-Hui Wang
Journal:  Psychopharmacology (Berl)       Date:  2019-01-03       Impact factor: 4.530

10.  Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory.

Authors:  Hila Abush; Irit Akirav
Journal:  Neuropsychopharmacology       Date:  2013-02-20       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.